Cargando…

Promises of Fibroblast Growth Factor Receptor–Directed Therapy in Tailored Cancer Treatment

Detalles Bibliográficos
Autores principales:	Fagoonee, Sharmila, Pellicano, Rinaldo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463988/ https://www.ncbi.nlm.nih.gov/pubmed/32784393 http://dx.doi.org/10.3390/jcm9082570

Ejemplares similares

One or Two Weeks of Treatment with Helicobacter pylori “Standard” Triple Therapy in the Year 2015?
por: Pellicano, Rinaldo, et al.
Publicado: (2015)

Does the Microbiota Play a Pivotal Role in the Pathogenesis of Irritable Bowel Syndrome?
por: Fagoonee, Sharmila, et al.
Publicado: (2019)

Response to: Reply on “Renewed Helicobacter pylori Management and Therapy in 2015”
por: Fagoonee, Sharmila, et al.
Publicado: (2016)

Trends in the Comprehension and Management of Gastrointestinal Tract Disorders
por: Durazzo, Marilena, et al.
Publicado: (2022)

The Evolving Incidence of Hepatitis C Virus Infection in Italy
por: Pellicano, Rinaldo, et al.
Publicado: (2012)

History of Inflammatory Bowel Diseases
por: Actis, Giovanni Clemente, et al.
Publicado: (2019)

Primary Biliary Cholangitis and Bile Acid Farnesoid X Receptor Agonists
por: Abenavoli, Ludovico, et al.
Publicado: (2020)

Helicobacter pylori and Respiratory Diseases: 2021 Update
por: Durazzo, Marilena, et al.
Publicado: (2021)

2013 Update on Celiac Disease and Eosinophilic Esophagitis
por: Pellicano, Rinaldo, et al.
Publicado: (2013)

Extra-Intestinal Manifestations of Celiac Disease: What Should We Know in 2022?
por: Durazzo, Marilena, et al.
Publicado: (2022)

Autoimmune Hepatitis and Fibrosis
por: Pellicano, Rinaldo, et al.
Publicado: (2023)

Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis
por: Caviglia, Gian Paolo, et al.
Publicado: (2021)

Targeted therapy: tailoring cancer treatment
por: Yan, Min, et al.
Publicado: (2013)

Incidence of Prostate Cancer in Inflammatory Bowel Disease: A Meta-Analysis
por: Carli, Edoardo, et al.
Publicado: (2020)

Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver Diseases
por: Cernigliaro, Viviana, et al.
Publicado: (2020)

Importance of Translational Research for Targeting Fibroblast Growth Factor Receptor Signaling in Cancer
por: Holzmann, Klaus, et al.
Publicado: (2019)

Targeting fibroblast growth factors in cancer
por: Baker, Kevin P., et al.
Publicado: (2013)

Smart Nanoformulations for Brain Cancer Theranostics: Challenges and Promises
por: Ahmad, Faraz, et al.
Publicado: (2022)

Regenerative Approaches and Future Trends for the Treatment of Corneal Burn Injuries
por: Saccu, Gabriele, et al.
Publicado: (2021)

A Retrospective Experience of Helicobacter pylori Histology in a Large Sample of Subjects in Northern Italy
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2021)

Microscopic colitis in patients with mild duodenal damage: A new clinical and pathological entity (“lymphocytic enterocolitis”)?
por: Bonagura, Gabriele Antonio, et al.
Publicado: (2016)

Rifabutin-Based Rescue Therapy for Helicobacter pylori Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2019)

Phytochemicals from Indian Ethnomedicines: Promising Prospects for the Management of Oxidative Stress and Cancer
por: Fatima, Nishat, et al.
Publicado: (2021)

Design and characteristics of cytotoxic fibroblast growth factor 1 conjugate for fibroblast growth factor receptor-targeted cancer therapy
por: Szlachcic, Anna, et al.
Publicado: (2016)

Fibroblast Growth Factor Signaling in Development and Disease
por: Bollenbecker, Seth, et al.
Publicado: (2023)

Etiology of chronic liver diseases in the Northwest of Italy, 1998 through 2014
por: Saracco, Giorgio Maria, et al.
Publicado: (2016)

Genetics and tailored therapy in cardiovascular disease
por: Doevendans, P. A., et al.
Publicado: (2011)

On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases
por: Caviglia, Gian Paolo, et al.
Publicado: (2020)

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
por: Sobhani, Navid, et al.
Publicado: (2018)

Good Things Come in 2s: Type 2 Alveolar Epithelial Cells and Fibroblast Growth Factor Receptor 2
por: Shimbori, Chiko, et al.
Publicado: (2020)

Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases
por: Bertani, Lorenzo, et al.
Publicado: (2020)

Aptamers: Promising Tools for Cancer Diagnosis and Therapy
por: Cerchia, Laura
Publicado: (2018)

Postbiotics as Promising Tools for Cancer Adjuvant Therapy
por: Homayouni Rad, Aziz, et al.
Publicado: (2021)

Towards a tailored systemic therapy for liver cancer
por: Sacco, Rodolfo, et al.
Publicado: (2020)

Fibroblast growth factor 2: good or bad guy in the joint?
por: Vincent, Tonia L
Publicado: (2011)

Fibroblast Growth Factor 21: A Novel Metabolic Regulator
por: Seo, Ji A, et al.
Publicado: (2012)

Fibroblast Growth Factor Inhibitors in Lung Fibrosis: Friends or Foes?
por: Guzy, Robert
Publicado: (2020)

Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts
Publicado: (1984)

Strategies for Helicobacter pylori eradication in the year 2020
por: Pellicano, Rinaldo, et al.
Publicado: (2020)

Acidic Fibroblast Growth Factor in Spinal Cord Injury: A Potential Therapy Which Merits Further Investigation
por: Yokota, Kazuya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kn1tcs69culcvvdmfkfalg11v9